MAVENCLAD 10 mg tablets

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	10

13. 多発性硬化症／視神経脊髄炎

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

trials per page:

Showing 1 to 10 of 10 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-003995-42-IT (EUCTR)	13/05/2021	04/06/2021	Extension to the MAGNIFY MS trial on Mavenclad®	A 2-year extension study to evaluate long-term effectiveness of Mavenclad® in participants who have ...	Highly-active relapsing multiple sclerosis MedDRA version: 21.1;Level: PT;Classification code 100633 ...	Trade Name: MAVENCLAD- 10 MG- COMPRESSA - USO ORALE - BLISTER (AL/AL) - 6 COMPRESSE Product Name: Cla ...	MERCK KGAA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	261	Phase 4	Hungary;Czech Republic;Canada;Finland;Poland;Australia;Israel;Germany;Italy
2	EUCTR2020-003995-42-AT (EUCTR)	26/01/2021	23/11/2020	Extension to the MAGNIFY MS trial on Mavenclad®	A 2-year extension study to evaluate long-term effectiveness of Mavenclad® in participants who have ...	Highly-active relapsing multiple sclerosis MedDRA version: 20.0;Level: SOC;Classification code 10029 ...	Trade Name: Mavenclad Product Name: Cladribine tablets Product Code: Not applicable INN or Proposed INN ...	Merck Healthcare KGaA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	256	Phase 4	Hungary;Czech Republic;Canada;Finland;Poland;Australia;Austria;Israel;Germany;Italy
3	EUCTR2020-003874-30-HU (EUCTR)	15/01/2021	20/11/2020	Cognition and HRQoL in adults with highly-active RMS in Year 3 and 4 after initial Mavenclad® dose	A 2-year follow-up study to assess cognition and health-related quality of life in participants with ...	Highly-active relapsing multiple sclerosis MedDRA version: 20.0;Level: SOC;Classification code 10029 ...	Trade Name: Mavenclad Product Name: Cladribine tablets Product Code: Not applicable INN or Proposed INN ...	Merck Healthcare KGaA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	320	Phase 4	Hungary
4	EUCTR2020-003874-30-IT (EUCTR)	08/01/2021	24/05/2021	Cognition and HRQoL in adults with highly-active RMS in Year 3 and 4 after initial Mavenclad® dose	A 2-year follow-up study to assess cognition and health-related quality of life in participants with ...	Highly-active relapsing multiple sclerosis MedDRA version: 20.0;Level: SOC;Classification code 10029 ...	Trade Name: MAVENCLAD- 10 MG- COMPRESSA - USO ORALE - BLISTER (AL/AL) - 6 COMPRESSE Product Name: Cla ...	MERCK KGAA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	320	Phase 4	France;Czechia;Hungary;Slovakia;Spain;Poland;Denmark;Austria;Netherlands;Italy
5	EUCTR2020-003874-30-AT (EUCTR)	29/12/2020	23/11/2020	Cognition and HRQoL in adults with highly-active RMS in Year 3 and 4 after initial Mavenclad® dose	A 2-year follow-up study to assess cognition and health-related quality of life in participants with ...	Highly-active relapsing multiple sclerosis MedDRA version: 20.0;Level: SOC;Classification code 10029 ...	Trade Name: Mavenclad Product Name: Cladribine tablets Product Code: Not applicable INN or Proposed INN ...	Merck Healthcare KGaA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	380	Phase 4	Hungary;Czech Republic;Denmark;Austria;Italy
6	EUCTR2020-003995-42-FI (EUCTR)	15/12/2020	23/11/2020	Extension to the MAGNIFY MS trial on Mavenclad®	A 2-year extension study to evaluate long-term effectiveness of Mavenclad® in participants who have ...	Highly-active relapsing multiple sclerosis MedDRA version: 20.0;Level: SOC;Classification code 10029 ...	Trade Name: Mavenclad Product Name: Cladribine tablets Product Code: Not applicable INN or Proposed INN ...	Merck Healthcare KGaA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	256	Phase 4	Canada;Finland;Australia;Israel;Germany
7	EUCTR2018-005038-39-GB (EUCTR)	02/12/2020	29/09/2020	A phase 2b study of Cladribine to halt deterioration in people with advanced multiple sclerosis	ChariotMS – A national (UK), multi-centre, randomised, double-blind, placebo-controlled (1:1) phase ...	Advanced Multiple Sclerosis (EDSS 6.5-8.5) MedDRA version: 20.1;Level: PT;Classification code 100282 ...	Trade Name: MAVENCLAD Product Name: MAVENCLAD INN or Proposed INN: Cladribine	Queen Mary University of London	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200	Phase 2	United Kingdom
8	EUCTR2019-000069-19-IT (EUCTR)	11/10/2019	01/09/2021	Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment with Cladribine Table ...	Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment with Cladribine Table ...	Multiple Sclerosis MedDRA version: 20.0;Level: SOC;Classification code 10029205;Term: Nervous system ...	Trade Name: MAVENCLAD Product Name: Cladribina Product Code: [Not applicable]	MERCK KGAA	NULL	Not Recruiting			Female: yes Male: yes	1000	Phase 4	United States;Portugal;Estonia;Morocco;Greece;Spain;Ukraine;Lebanon;Russian Federation;Switzerland;I ...
9	EUCTR2019-000069-19-ES (EUCTR)	23/08/2019	04/07/2019	Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment with Cladribine Table ...	Evaluating the Long-Term Outcomes and Durability of Effect Following Treatment with Cladribine Table ...	Multiple Sclerosis MedDRA version: 20.0;Level: SOC;Classification code 10029205;Term: Nervous system ...	Trade Name: MAVENCLAD Product Name: Cladribine tablets Product Code: Not applicable INN or Proposed INN ...	Merck KGaA	NULL	Not Recruiting			Female: yes Male: yes	1000	Phase 4	United States;Serbia;Portugal;Estonia;Morocco;Greece;Spain;Ukraine;Lebanon;Russian Federation;Switze ...
10	EUCTR2018-004557-24-DE (EUCTR)	29/07/2019	18/06/2019	Clarifying the mechanism of action of cladribine in relapsing multiple sclerosis	Clarifying the mechanism of action of cladribine in relapsing multiple sclerosis - ClaiMS, Cladribin ...	Multiple Sclerosis MedDRA version: 20.1;Level: PT;Classification code 10028245;Term: Multiple sclero ...	Trade Name: MAVENCLAD 10 mg tablets INN or Proposed INN: CLADRIBINE	Westfälische Wilhelms-Universität Münster c/o Universitätsklinikum Münster, Geschäftsbereich Recht u ...	NULL	Not Recruiting			Female: yes Male: yes	30	Phase 4	Germany

First Previous1Next Last